Explore Watchlists Pricing

ABBOTT LABORATORIES (ABT) Income statement

Market cap

$165.9B

P/E ratio

25.7x

Summary Financials

Income statement Balance sheet Cash flow Other

	2010/12	2011/12	2013/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Revenue	35,167	38,851	21,848	20,405	20,853	27,390	30,578	31,904	34,608	43,075	43,653	40,109	41,950	44,328
Revenue growth (%)	-		-	-
Cost of revenue	14,665	15,541	10,040	8,747	9,024	12,337	12,706	13,231	15,003	18,537	19,142	17,975	18,706	19,319
Research & development	-	-	-	-	-	-	-	2,440	2,420	2,742	2,888	2,741	2,844	2,942
Selling, general & administrative	10,376	12,757	6,936	6,785	6,672	9,117	9,744	9,765	9,696	11,324	11,248	10,949	11,697	12,332
Operating margin (%)
Operating expenses	29,079	33,099	19,219	17,538	17,668	25,664	26,928	27,372	29,251	34,650	35,291	33,631	35,125	36,275
Operating income	6,088	5,752	2,629	2,867	3,185	1,726	3,650	4,532	5,357	8,425	8,362	6,478	6,825	8,053
Income before tax	5,713	5,199	2,521	3,183	1,413	2,231	2,873	4,077	4,968	8,211	8,306	6,664	7,013	8,466
Pretax margin (%)	16.2	13.4	11.5	15.6	6.8	8.1	9.4	12.8	14.4	19.1	19	16.6	16.7	19.1
Provision for income taxes	1,087	470	138	577	350	1,878	539	390	497	1,140	1,373	941	-6,389	1,942
Effective tax rate (%)
Net income	4,626	-	2,576	4,423	1,400	477	2,368	3,687	4,495	7,071	6,933	5,723	13,402	6,524
Net income margin (%)		-
Earnings per share	2.98	3.03	1.64	2.94	0.94	0.27	1.34	2.07	2.52	3.97	3.94	3.28	7.67	3.73
Diluted EPS	2.96	3.01	1.62	2.92	0.94	0.27	1.33	2.06	2.5	3.94	3.91	3.26	7.64	3.72
Dividend payout ratio (%)	-		-	-	-	-	-	-	-	-	-	-
Dividend per share	-	1.92	-	-	-	-	-	-	-	-	-	-	2.24	2.4